Table 3. Inhalation of drugs for breathing problems by gender. *significant for p<0.05.
Questions | Gender (N=1200) | p | |||
---|---|---|---|---|---|
Male | Female | Total | |||
Have you used any inhaled medicines e.g. puffers to help your breathing problems at any time in the past 12 MONTHS (when you didn’t have a cold)? (N=1200) | |||||
Yes | N | 60 | 40 | 100 | Pearson Chi-square: 3.1858; df=1; p=0.0743 |
% | 9.71% | 6.87% | 8.33% | ||
No | N | 558 | 542 | 1100 | |
% | 90.29% | 93.13% | 91.67% | ||
Have you used Short acting β- agonists (SABA) in the past 12 MONTHS? (N=1200) | |||||
Never | N | 584 | 561 | 1145 | Never/ when needed/ in short courses+every day Pearson Chi-square: 3.1101; df=2; p=0.2110 |
% | 94.50% | 96.39% | 95.42% | ||
When needed | N | 26 | 18 | 44 | |
% | 4.21% | 3.09% | 3.67% | ||
In short courses | N | 3 | 2 | 5 | |
% | 0.49% | 0.34% | 0.42% | ||
Every day | N | 5 | 1 | 6 | |
% | 0.81% | 0.17% | 0.50% | ||
Have you used Long acting β- agonists (LABA) in the past 12 MONTHS? (N=1200) | |||||
Never | N | 603 | 573 | 1176 | Never/ when needed+ in short courses Pearson Chi-square: 1.1901; df=2; p=0.2760 |
% | 97.57% | 98.45% | 98% | ||
When needed | N | 13 | 9 | 22 | |
% | 2.10% | 1.55% | 1.83% | ||
In short courses | N | 2 | 0 | 2 | |
% | 0.32% | 0% | 0.17% | ||
Have you used Inhaled corticosteroids (ICS) in the past 12 MONTHS? (N=1200) | |||||
Never | N | 602 | 571 | 1173 | Never/ when needed/ in short courses+every day Pearson Chi-square: 1.2301; df=2; p=0.5420 |
% | 97.41% | 98.11% | 97.75% | ||
When needed | N | 11 | 9 | 20 | |
% | 1.78% | 1.55% | 1.67% | ||
In short courses | N | 5 | 0 | 5 | |
% | 0.81% | 0% | 0.42% | ||
Every day | N | 0 | 2 | 2 | |
% | 0% | 0.34% | 0.17% | ||
Have you used Combination ICS and LABA in the past 12 MONTHS? (N=1200) | |||||
Never | N | 604 | 573 | 1177 | Never/ when needed+ in short courses Pearson Chi-square: 0,8240; df=1; p=0.3640 |
% | 97.73% | 98.45% | 98.08% | ||
When needed | N | 12 | 8 | 20 | |
% | 1.94% | 1.37% | 1.67% | ||
In short courses | N | 2 | 1 | 3 | |
% | 0.32% | 0.17% | 0.25% |